Gene Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
Entrez Id: 4311
Gene Symbol: MME
MME
0.020 Biomarker disease BEFREE The analysis of CD10, Ki-67, and PHLDA1 can be used as a helpful immunohistochemical panel in the distinction between TE and BCC especially in small and superficial biopsies. 29917261 2018
Entrez Id: 4311
Gene Symbol: MME
MME
0.020 AlteredExpression disease BEFREE Peripheral epithelial expression of CD10 was also found in Pinkus tumors (9/21 [42.9 %]) and trichoepithelioma (4/11 [36.4 %]). 29873924 2018
Entrez Id: 3265
Gene Symbol: HRAS
HRAS
0.020 GeneticVariation disease BEFREE A multigene hotspot mutational profiling of the BRAF, NRAS, HRAS and KRAS genes was carried out, and a shared G13R HRAS mutation in both the trichoblastoma and the sebaceous nevus components was found. 28554764 2017
Entrez Id: 3265
Gene Symbol: HRAS
HRAS
0.020 GeneticVariation disease BEFREE Using a RAS SNaPshot assay, HRAS mutations were detected in 2 (11%) of 18 sporadic TB and 6 (26%) of 23 sporadic syringocystadenoma papillifera. 25532942 2015
Entrez Id: 2735
Gene Symbol: GLI1
GLI1
0.020 AlteredExpression disease BEFREE Quantification of Gli1 transcripts by RT-PCR is helpful in discriminating BCC and trichoepithelioma from other skin tumors. 15606671 2005
Entrez Id: 2735
Gene Symbol: GLI1
GLI1
0.020 Biomarker disease BEFREE In the present study, we show that mice ectopically expressing the human Cubitus interruptus homolog GLI-1 in the skin develop tumors closely resembling human BCCs as well as other hair follicle-derived neoplasias, such as trichoepitheliomas, cylindromas, and trichoblastomas. 10725363 2000
Entrez Id: 794
Gene Symbol: CALB2
CALB2
0.010 AlteredExpression disease BEFREE Calretinin was expressed in 4/6 cases of PTT and negative in all TB. 31012094 2019
Entrez Id: 7157
Gene Symbol: TP53
TP53
0.010 AlteredExpression disease BEFREE High-grade trichoblastic carcinoma arising through malignant transformation of trichoblastoma: Immunohistochemical analysis and the expression of p53 and phosphorylated AKT. 30379345 2019
Entrez Id: 947
Gene Symbol: CD34
CD34
0.010 Biomarker disease BEFREE Only one malignant case of PTT was positive for CD34 (1/2) and negative in all TB cases. 31012094 2019
Entrez Id: 207
Gene Symbol: AKT1
AKT1
0.010 AlteredExpression disease BEFREE High-grade trichoblastic carcinoma arising through malignant transformation of trichoblastoma: Immunohistochemical analysis and the expression of p53 and phosphorylated AKT. 30379345 2019
Entrez Id: 22822
Gene Symbol: PHLDA1
PHLDA1
0.010 Biomarker disease BEFREE The analysis of CD10, Ki-67, and PHLDA1 can be used as a helpful immunohistochemical panel in the distinction between TE and BCC especially in small and superficial biopsies. 29917261 2018
Entrez Id: 51684
Gene Symbol: SUFU
SUFU
0.010 GeneticVariation disease BEFREE Certain phenotypic features have been identified as being more prevalent in individuals with a SUFU mutation such as childhood medulloblastoma, infundibulocystic BCCs and trichoepitheliomas. 29356994 2018
Entrez Id: 8549
Gene Symbol: LGR5
LGR5
0.010 AlteredExpression disease BEFREE LGR5 expression was highest in basal cell carcinomas (BCCs) followed by trichoepitheliomas (TEs) and basaloid follicular hamartomas. 28070642 2017
Entrez Id: 26585
Gene Symbol: GREM1
GREM1
0.010 AlteredExpression disease BEFREE Tissue microarrays analyzed by RNA ISH for GREM1 expression also demonstrated that 23% of BCCs, 42% of squamous cell carcinomas, 20% of melanomas, and 90% of PMCs were positive for GREM1 expression, whereas trichoepitheliomas, eccrine poromas, hidradenomas, and spiradenomas were negative for GREM1 expression. 28346486 2017
Entrez Id: 59352
Gene Symbol: LGR6
LGR6
0.010 AlteredExpression disease BEFREE Interestingly, LGR6 expression was detected in stromal cells around the tumor and papillary mesenchymal bodies of TEs but not in stromal cells of BCCs, suggesting different characteristics of tumor-associated fibroblasts between TEs and BCCs. 28070642 2017
Entrez Id: 673
Gene Symbol: BRAF
BRAF
0.010 GeneticVariation disease BEFREE No BRAF mutation could be detected in 3 syringocystadenoma papillifera secondarily arisen from a sebaceous nevus as well as in sporadic TB. 25532942 2015
Entrez Id: 2475
Gene Symbol: MTOR
MTOR
0.010 Biomarker disease BEFREE Immunohistochemical analysis of the mechanistic target of rapamycin and hypoxia signalling pathways in basal cell carcinoma and trichoepithelioma. 25181405 2014
Entrez Id: 3091
Gene Symbol: HIF1A
HIF1A
0.010 AlteredExpression disease BEFREE Among 45 BCC and 35 TE examined, expression levels were respectively 81% and 57% (BNIP3), 73% and 75% (CAIX), 79% and 86% (GLUT1), 50% and 19% (HIF1α), 89% and 88% (pAKT), 55% and 61% (pS6), 15% and 25% (pMTOR), 44% and 63% (PHD2) and 44% and 49% (VEGF-A). 25181405 2014
Entrez Id: 6513
Gene Symbol: SLC2A1
SLC2A1
0.010 AlteredExpression disease BEFREE CAIX, Glut1 and PHD2 expression levels were significantly higher in TE when only samples with at least 80% expression were included. 25181405 2014
Entrez Id: 29072
Gene Symbol: SETD2
SETD2
0.010 AlteredExpression disease BEFREE We used immunohistochemical staining of formalin-fixed paraffin-embedded BCC (n = 45) and TE (n = 35) samples to assess activity of HIF1, mTORC1 and their most important target genes. 25181405 2014
Entrez Id: 54583
Gene Symbol: EGLN1
EGLN1
0.010 AlteredExpression disease BEFREE CAIX, Glut1 and PHD2 expression levels were significantly higher in TE when only samples with at least 80% expression were included. 25181405 2014
Entrez Id: 664
Gene Symbol: BNIP3
BNIP3
0.010 AlteredExpression disease BEFREE Among 45 BCC and 35 TE examined, expression levels were respectively 81% and 57% (BNIP3), 73% and 75% (CAIX), 79% and 86% (GLUT1), 50% and 19% (HIF1α), 89% and 88% (pAKT), 55% and 61% (pS6), 15% and 25% (pMTOR), 44% and 63% (PHD2) and 44% and 49% (VEGF-A). 25181405 2014
Entrez Id: 1540
Gene Symbol: CYLD
CYLD
0.010 GeneticVariation disease BEFREE The authors report the case of a 9-year-old African girl with multiple facial trichoepitheliomas in whom a mutation in the CYLD gene was hypothesised. 19929939 2010
Entrez Id: 367
Gene Symbol: AR
AR
0.010 AlteredExpression disease BEFREE Androgen receptor expression was significantly higher in fibroepitheliomas of Pinkus compared with trichoepitheliomas and trichoblastomas (P = .0007), but not basal cell carcinoma (P = 1.00). 17284955 2007
Entrez Id: 5727
Gene Symbol: PTCH1
PTCH1
0.010 GeneticVariation disease BEFREE We therefore screened 10 sporadic trichoblastomas and 1 trichoblastoma arising within a nevus sebaceus for PTCH mutations. 17597182 2007